Our results indicate for the first time that GDF15 could be regulated by MEK1/Erk1 signaling pathway, at least in the less aggressive brain cancer cells, while it could also act as a negative regulator of MEK1/Erk1 activation in order to regulate its expression levels in compressed brain cancer cells. This evidence concerns the gene MAP2K1 and brain cancer.